PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30052039-0	2018	Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties.	1,2,3,4-tetrahydroisoquinoline	71-93	chemokine (C-X-C motif) receptor 4	Mus musculus	100-105	
30052039-3	2018	We previously disclosed a hit-to-lead effort that led to the discovery of a series of tetrahydroisoquinoline-based CXCR4 antagonists exemplified by the lead compound TIQ15.	1,2,3,4-tetrahydroisoquinoline	86-108	chemokine (C-X-C motif) receptor 4	Mus musculus	115-120	
34676043-0	2021	Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald Couplings.	1,2,3,4-tetrahydroisoquinoline	18-40	chemokine (C-X-C motif) receptor 4	Mus musculus	41-46